Table 2.
The baseline data of the acute phase group and the subacute phase group.
| Patients | Acute zoster group (n = 47) | Subacute zoster group (n = 36) | p |
|---|---|---|---|
| Age (years, x ± SD) | 69.91 ± 11.0 | 70.08 ± 8.4 | 0.939 |
| Gender, male (%) | 23 (48.93%) | 20 (55.56%) | 0.550 |
| Weight | 64.11 ± 12.2 | 62.52 ± 9.2 | 0.524 |
| Side, left (%) | 18 (38.30%) | 12 (33.33%) | 0.641 |
| Branch affected, n (%) | 0.557 | ||
| I | 14 (29.79%) | 15 (41.67%) | |
| II | 8 (17.02%) | 3 (8.33%) | |
| III | 14 (29.79%) | 10 (27.78%) | |
| I + II | 5 (10.64%) | 3 (8.33%) | |
| II + III | 6 (12.77%) | 5 (13.89%) | |
| Comorbidities, n (%) | 0.481 | ||
| Hypertension | 10 (21.28%) | 5 (13.89%) | |
| Diabetes mellitus | 5 (10.64%) | 7 (19.44%) | |
| Coronary disease | 3 (6.38%) | 3 (8.33%) | |
| Stroke | 2 (4.26%) | 2 (5.56%) | |
| Preoperative NRS score | 7.29 ± 1.54 | 7.31 ± 1.24 | 0.927 |
| Days after zoster onset (days) | 24.21 ± 5.3 | 48.81 ± 13.4 | — |
| Preoperative PSQI score | 19.34 ± 1.94 | 19.36 ± 2.72 | 0.968 |
| Preoperative dose of pregabalin (mg/d) | 244.15 ± 57.39 | 243.75 ± 57.75 | 0.975 |
| Preoperative dose of tramadol (mg/d) | 234.04 ± 47.89 | 244.44 ± 47.89 | 0.344 |
| Intraoperative voltage (V) | 64.21 ± 12.32 | 66.56 ± 9.32 | 0.761 |
Notes: Values are presented as mean ± standard deviation.
Abbreviations: NRS, Numerical Rating Scale; PSQI, Pittsburgh Sleep Quality Index.